Skip to Content

Schedule An Appointment

For exceptional cancer care close to home, call:


Other Treatment Options for Prostate Cancer

Hormonal Medications

Recently approved newer medications also affect the male hormones in the body, which can have a positive effect treating prostate cancer. These agents (enzalutamide and abiraterone) now have proven effectiveness in improving survival and delaying progression in advanced metastatic disease. These agents may be used after failure of standard hormonal therapies and are generally well tolerated. Side effects may include fatigue, electrolyte abnormalities, high blood pressure and swelling in the legs. These agents are not currently used in men who have newly diagnosed or localized prostate cancer. 

Vaccine Therapy/Immunotherapy

Sipuleucel-T is the first immunotherapy or vaccine therapy approved by the FDA for advanced prostate cancer treatment. In certain men with advanced prostate cancer, who have progression despite hormonal therapies, this therapy has been demonstrated to improve survival. It is an option for select men who have demonstrated progression of metastatic disease after failure of initial hormonal therapy but remain relatively asymptomatic.


Radium-223 is a radiopharmaceutical, which is a medical form of radiation treatment administered intravenously. It circulates throughout the body and into the bone. It has proven advantages for men who have advanced metastatic prostate cancer to the bone and are symptomatic (have pain) related to their bone lesions. This therapy is a proven method for improving survival and decreasing pain for patients in this situation.


Chemotherapy is drug therapy administered to the entire body to kill cancer cells.  Currently, chemotherapy is most commonly used for prostate cancers that have spread beyond the prostate. These drugs are very powerful and work by killing cancer cells, which tend to be fast-growing cells.            

Unfortunately, chemotherapy is not very selective and also kills other cells in the body that grow and divide quickly. The resulting side effects include anemia, weakness, fatigue, nausea, diarrhea, etc. While chemotherapy rarely cures prostate cancer, recent research has found particular chemotherapy regimens (docetaxel-based) can improve survival in certain patients with advanced disease. Recently, second line chemotherapy (cabazitaxel) has been approved as a result of studies demonstrating effectiveness in men who fail first line therapy.

Experimental Therapies

With high-intensity focused ultrasound (HIFU), acoustic energy is used with ultrasound focusing to generate heat within the prostate to either kill focal areas of the prostate or the entire prostate gland. This type of therapy can be repeated. Side effects may include fistula, urinary leakage, urethral stricture, perineal pain and erectile dysfunction. Currently, HIFU is not FDA approved for the treatment of prostate cancer in the United States, and there is insufficient information to recommend it as a standard therapy. However, some men have chosen to have HIFU treatment with the understanding that it should be considered experimental at this time. 

Like HIFU, with radiofrequency interstitial tumor ablation, heat is used to selectively kill prostate cancer cells. At this time, long term results and information regarding complications and cancer control are not available.  

Related Content

  • Prostate Cancer Awareness: What You Should Know

    Prostate Cancer Awareness: What You Should Know

    September is Prostate Cancer Awareness Month. Get answers to common questions, debunk myths and learn about risk factors from Lester Borden, MD, in this 2 Your Well-Being discussion with WFMY News 2.
    September 6, 2022
  • Prostate Cancer: When Should You Be Screened?

    Prostate Cancer: When Should You Be Screened?

    Robin Bass, RN, BSN, OCN, talks about what you should know about prostate cancer, including risk factors and screening recommendations.
    September 23, 2019
  • Lester Borden, MD

    What Men of All Ages Should Know About Prostate Cancer

    Prostate cancer is the most common form of cancer in men. It’s important for men of all ages and the women in their lives to understand the risk factors, symptoms and screening recommendations for prostate cancer. Lester Borden, MD, Cone Health Genitourinary Cancer Medical Director, reviews what you should know about prostate cancer.
    September 10, 2019